首页> 美国卫生研究院文献>Journal of Biomedical Science >Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats
【2h】

Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats

机译:表达和分泌异源草酸脱羧酶的重组植物乳杆菌可防止实验大鼠肾脏草酸钙结石沉积

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCalcium oxalate (CaOx) is the major constituent of about 75% of all urinary stone and the secondary hyperoxaluria is a primary risk factor. Current treatment options for the patients with hyperoxaluria and CaOx stone diseases are limited. Oxalate degrading bacteria might have beneficial effects on urinary oxalate excretion resulting from decreased intestinal oxalate concentration and absorption. Thus, the aim of the present study is to examine the in vivo oxalate degrading ability of genetically engineered Lactobacillus plantarum (L. plantarum) that constitutively expressing and secreting heterologous oxalate decarboxylase (OxdC) for prevention of CaOx stone formation in rats. The recombinants strain of L. plantarum that constitutively secreting (WCFS1OxdC) and non-secreting (NC8OxdC) OxdC has been developed by using expression vector pSIP401. The in vivo oxalate degradation ability for this recombinants strain was carried out in a male wistar albino rats. The group I control; groups II, III, IV and V rats were fed with 5% potassium oxalate diet and 14th day onwards group II, III, IV and V were received esophageal gavage of L. plantarum WCFS1, WCFS1OxdC and NC8OxdC respectively for 2-week period. The urinary and serum biochemistry and histopathology of the kidney were carried out. The experimental data were analyzed using one-way ANOVA followed by Duncan’s multiple-range test.
机译:背景草酸钙(CaOx)是所有尿路结石中约75%的主要成分,继发性高草酸尿症是主要的危险因素。高草酸尿症和CaOx结石病患者的当前治疗选择有限。草酸盐降解细菌可能由于肠道草酸盐浓度和吸收降低而对尿草酸盐排泄产生有益影响。因此,本研究的目的是检验组成型表达和分泌异源草酸脱羧酶(OxdC)的转基因植物乳杆菌(L. plantarum)在体内的草酸盐降解能力,以预防大鼠CaOx结石形成。通过使用表达载体pSIP401,开发了组成型分泌(WCFS10xdC)和非分泌性(NC8OxdC)OxdC的植物乳杆菌重组菌株。该重组菌株的体内草酸盐降解能力是在雄性wistar白化病大鼠中进行的。我控制的小组;第II,III,IV和V组大鼠饲喂5%草酸钾饮食,第14天起,第II,III,IV和V组食管饲喂植物乳杆菌WCFS1,WCFS1OxdC和NC8OxdC分别为期2周。进行了肾脏的尿液和血清生化及组织病理学检查。使用单向方差分析和邓肯的多范围测试对实验数据进行了分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号